RNA modifications and cancer
RNA modifications and cancer is a research topic within Molecular Biology. Science Explorer counts 89k research works in it since 1950. 23.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the diverse landscape of RNA methylation, with a focus on m6A modification, its impact on gene expression, ribosome biogenesis, and its role in cancer progression. The research covers various aspects such as m6A-seq, tRNA fragments, YTHDF proteins, and the involvement of methyltransferases in mRNA modification.
- m6A-seq
- RNA methylation
- mRNA modification
- epitranscriptome
- ribosome biogenesis
- tRNA fragments
- YTHDF proteins
- cancer progression
- methyltransferases
- gene expression regulation
- Research works
- 89k fractional, since 1950
- In the world top 10%
- 21k per year above
- Top-10% rate
- 23.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +43% the tick is no change
Which countries lead RNA modifications and cancer research?
By volume, China and the United States publish the most (8.8k and 3.9k works in 2022–2025).
By volume, 2022–2025
- 1 China 8.8k works
- 2 United States 3.9k works
- 3 Germany 606 works
- 4 Japan 573 works
- 5 India 564 works
- 6 United Kingdom 462 works
- 7 France 391 works
- 8 Italy 342 works
- 9 South Korea 312 works
- 10 Canada 308 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead RNA modifications and cancer research?
By volume in 2022–2025, Sun Yat-sen University publishes the most RNA modifications and cancer research, followed by Central South University and Nanjing Medical University.
By volume, 2022–2025
- 1 Sun Yat-sen University China 160 works
- 2 Central South University China 126 works
- 3 Nanjing Medical University China 121 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical College China 108 works
- 5 Shanghai Jiao Tong University China 102 works
- 6 China Medical University China 100 works
- 7 Zhejiang University China 94 works
- 8 Wuhan University China 94 works
- 9 Sichuan University China 88 works
- 10 Huazhong University of Science and Technology China 78 works
Who are the leading researchers in RNA modifications and cancer?
The most-cited researchers publishing on RNA modifications and cancer include Eric S. Lander, Stacey Gabriel and Vamsi K. Mootha.
- 1 Eric S. Lander 8.5k citations
- 2 Stacey Gabriel 7.8k citations
- 3 Vamsi K. Mootha 6.9k citations
- 4 Benjamin L. Ebert 6.7k citations
- 5 Jill P. Mesirov 6.3k citations
- 6 Gad Getz 6.2k citations
- 7 Hermann Brenner 5.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is RNA modifications and cancer research done?
The largest centres of RNA modifications and cancer research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China). Among places with at least 20 works in it, it is an unusually large share of all research in Chevy Chase and Nantong.
Largest cities, 2022–2025
Where it is the local speciality
- Chevy ChaseUS · 35.2 works22×
- NantongCN · 84.9 works10×
Location quotient: how much more of its research is in RNA modifications and cancer than the world average.
Where is the best place to study RNA modifications and cancer?
Among universities, judged by research, Center for Life Sciences, Shanghai Medical College of Fudan University and Harbin Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Center for Life Sciences China | 74.3 | 44.4% | 23.6× | 23 | +589.6% |
| 2 | Shanghai Medical College of Fudan University China | 70.9 | 45.8% | 17.0× | 25 | +157.3% |
| 3 | Harbin Medical University China | 66.1 | 23.2% | 20.9× | 76 | +164.6% |
| 4 | Nanjing Medical University China | 66.0 | 27.4% | 13.2× | 121 | +68.3% |
| 5 | Guangzhou Medical University China | 65.4 | 26.0% | 13.3× | 65 | +134.1% |
| 6 | China Medical University China | 64.0 | 26.2% | 17.2× | 100 | +70.7% |
| 7 | Anhui Medical University China | 62.9 | 27.7% | 10.0× | 54 | +112.4% |
| 8 | Shandong First Medical University China | 62.8 | 29.7% | 9.7× | 45 | +120.8% |
| 9 | Sun Yat-sen University China | 61.1 | 32.5% | 5.5× | 160 | +91.5% |
| 10 | Southern Medical University China | 60.7 | 30.1% | 9.2× | 60 | +69.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is RNA modifications and cancer research growing?
Output in 2018–2022 was 43% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are RNA modifications and cancer.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.